Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake

Peptides

Volumn 31, Issue 9, 2010, Pages 1706-1710

  Li, Jiang Bo ^a   Asakawa, Akihiro ^a   Terashi, Mutsumi ^a   Cheng, Kaichun ^a   Chaolu, Huhe ^a   Zoshiki, Takahiro ^a   Ushikai, Miharu ^a   Sheriff, Sulaiman ^b   Balasubramaniam, Ambikaipakan ^b   Inui, Akio ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Body weight; BVD 74D; Food intake; Mouse; Obesity; Y4 receptor

Indexed keywords

BVD 74D; NEUROPEPTIDE Y RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ARTICLE; DRUG DOSE COMPARISON; DRUG SELECTIVITY; FATTY LIVER; FLUID INTAKE; FOOD INTAKE; LIPID DIET; OBESITY; PRIORITY JOURNAL; RECEPTOR AFFINITY; WEIGHT GAIN;

ANIMALS; ANTI-OBESITY AGENTS; ANXIETY; APPETITE DEPRESSANTS; APPETITE REGULATION; BEHAVIOR, ANIMAL; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; FATTY LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PEPTIDES; RECEPTORS, NEUROPEPTIDE Y; TIME FACTORS; WEIGHT GAIN;

MUS;

EID: 77955657561     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.06.011     Document Type: Article

References (51)

1. B. Antuna-Puente, B. Feve, S. Fellahi, and J.P. Bastard Adipokines: the missing link between insulin resistance and obesity Diabetes Metab 34 2008 2 11
2. A. Asakawa, A. Inui, H. Yuzuriha, N. Ueno, G. Katsuura, and M. Fujimiya Characterization of the effects of pancreatic polypeptide in the regulation of energy balance Gastroenterology 124 2003 1325 1336
3. A. Balasubramaniam, V.C. Dhawan, D.E. Mullins, W.T. Chance, S. Sheriff, and M. Guzzi Highly selective and potent neuropeptide Y (NPY) Y1 receptor antagonists based on [Pro (30), Tyr (32), Leu (34)] NPY (28-36)-NH2 (BW1911U90) J Med Chem 44 2001 1479 1482
4. A. Balasubramaniam, D.E. Mullins, S. Lin, W. Zhai, Z. Tao, and V.C. Dhawan Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY (32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity J Med Chem 49 2006 2661 2665
5. A. Balasubramaniam, R. Joshi, C. Su, L.A. Friend, and J.H. James Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists Peptides 28 2007 235 240
6. R.L. Batterham, M.A. Cohen, S.M. Ellis, C.W. Le Roux, D.J. Withers, and G.S. Frost Inhibition of food intake in obese subjects by peptide YY3-36 N Engl J Med 349 2003 941 948
7. M. Bitran, A.J. Daniels, and M.P. Boric GW1229, a novel neuropeptide Y Y1 receptor antagonist, inhibits the vasoconstrictor effect on neuropeptide Y in the hamster microcirculation Eur J Pharmacol 319 1997 43 47
8. A.G. Blomqvist, and H. Herzog Y-receptor subtypes - how many more? Trends Neurosci 20 1997 294 298
9. C. Cabrele, and A.G. Beck-Sickinger Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family J Pept Sci 6 2000 97 122
10. J.T. Clark, P.S. Kalra, W.R. Crowley, and S.P. Kalra Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats Endocrinology 115 1984 427 429
11. M. Cnop, P.J. Havel, K.M. Utzschneider, D.B. Carr, M.K. Sinha, and E.J. Boyko Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46 2003 459 469
12. Y. Dumont, A. Fournier, S. St-Pierre, and R. Quirion Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I] [Leu31, Pro34] peptide YY and [125I] peptide YY3-36 as selective Y1 and Y2 radioligands J Pharmacol Exp Ther 272 1995 673 680
13. N. Erondu, T. Wadden, I. Gantz, B. Musser, A.M. Nguyen, and H. Bays Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss Obesity (Silver Spring) 15 2007 895 905
14. R.L. Gingerich, M. Nagulesparan, L. Bennion, E.S. Dye, and W.A. Bauman Pancreatic polypeptide in Pima Indians: the influence of obesity and diabetes Metabolism 34 1985 25 29
15. B. Glaser, G. Zoghlin, K. Pienta, and A.I. Vinik Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance Horm Metab Res 20 1988 288 292
16. P. Gregor, Y. Feng, L.B. DeCarr, L.J. Cornfield, and M.L. McCaleb Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue J Biol Chem 271 1996 27776 27781
17. I.G. Halatchev, K.L. Ellacott, W. Fan, and R.D. Cone Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism Endocrinology 145 2004 2585 2590
18. M. Henry, L. Ghibaudi, J. Gao, and J.J. Hwa Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors Obes Res 13 2005 36 47
19. V.A. Holm The diagnosis of Prader-Willi syndrome V.A. Holm, S.J. Sulzbacher, P.L. Pipes, Prader-Willi syndrome 1979 University Park Press Baltimore, MD 27 45
20. K. Hotta, T. Funahashi, N.L. Bodkin, H.K. Ortmeyer, Y. Arita, and B.C. Hansen Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys Diabetes 50 2001 1126 1133
21. A. Kanatani, A. Ishihara, H. Iwaasa, K. Nakamura, O. Okamoto, and M. Hidaka L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist Biochem Biophys Res Commun 272 2000 169 173
22. H. Kawahara, and S. Takase Mutation of mitochondrial DNA in patients with non-alcoholic steatohepatitis Nippon Rinsho 64 2006 1095 1099
23. W.C. Knowler, D.J. Pettitt, M.F. Saad, and P.H. Bennett Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis Diabetes Metab Rev 6 1990 1 27
24. J. Koska, A. DelParigi, B. de Courten, C. Weyer, and P.A. Tataranni Pancreatic polypeptide is involved in the regulation of body weight in Pima Indian male subjects Diabetes 53 2004 3091 3096
25. T.A. Larsson, B.H. Tay, G. Sundström, R. Fredriksson, S. Brenner, and D. Larhammar Neuropeptide Y-family peptides and receptors in the elephant shark, Callorhinchus milii confirm gene duplications before the gnathostome radiation Genomics 93 2009 254 260
26. V. Lassmann, P. Vague, B. Vialettes, and M.C. Simon Low plasma levels of pancreatic polypeptide in obesity Diabetes 29 1980 428 430
27. D. Lindner, J. Stichel, and A.G. Beck-Sickinger Molecular recognition of the NPY hormone family by their receptors Nutrition 24 2008 907 917
28. F. Malaisse-Lagae, J.L. Carpentier, Y.C. Patel, W.J. Malaisse, and L. Orci Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis Experientia 33 1977 915 917
29. J. Marco, M.A. Zulueta, I. Correas, and M.L. Villanueva Reduced pancreatic polypeptide secretion in obese subjects J Clin Endocrinol Metab 50 1980 744 747
30. D.M. Mctigue, N.K. Edwards, and R.C. Rogers Pancreatic polypeptide in dorsal vagal complex stimulates gastric acid secretion and motility in rats Am J Physiol 265 1993 G1169 G1176
31. S. Meryn, D. Stein, and E.W. Straus Fasting and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity Metabolism 35 1986 798 802
32. S.L. Parker, M.S. Parker, A. Buschauer, and A. Balasubramaniam Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides Eur J Pharmacol 474 2003 31 42
33. A.E. Petro, and R.S. Surwit The C57BL/6J mouse as a model of diet-induced type 2 diabetes and obesity A.A.F. Sima, E. Sfrir, Animal models of diabetes: a primer 2001 Harwood Academic Publishers Australia 343 355
34. D.J. Pettitt, P.P. Moll, W.C. Knowler, D.M. Mott, R.G. Nelson, and M.F. Saad Insulinemia in children at low and high risk for NIDDM Diabetes Care 16 1993 608 615
35. R.C. Rogers, D.M. McTigue, and G.E. Hermann Vagal control of digestion: modulation by central neural and peripheral endocrine factors Neurosci Biobehav Rev 20 1996 57 66
36. K. Rudolf, W. Eberlein, W. Engel, H.A. Wieland, K.D. Willim, and M. Entzeroth The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226 Eur J Pharmacol 271 1994 11 13
37. M. Soga, Y. Kishimoto, J. Kawaguchi, Y. Nakai, Y. Kawamura, and S. Inagaki The FLS mouse: a new inbred strain with spontaneous fatty liver Lab Anim Sci 49 1999 269 275
38. G.R. Soodini Adiponectin and leptin in relation to insulin sensitivity Metab Syndr Relat Disord 2 2004 114 123
39. A. Souli, J. Chariot, T. Voisin, O. Presset, A. Tsocas, and A. Balasubramaniam Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo Peptides 18 1997 551 557
40. B.G. Stanley, and S.F. Leibowitz Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus Life Sci 35 1984 2635 2642
41. K. Tatemoto, and V. Mutt Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides Nature 285 1980 417 418
42. K. Tatemoto, M. Carlquist, and V. Mutt Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide Nature 296 1982 659 660
43. I.R. Tough, N.D. Holliday, and H.M. Cox Y (4) receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa J Pharmacol Exp Ther 319 2006 20 30
44. A.V. Turnbull, L. Ellershaw, D.J. Masters, S. Birtles, S. Boyer, and D. Carroll Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats Diabetes 51 2002 2441 2449
45. N. Ueno, A. Inui, M. Iwamoto, T. Kaga, A. Asakawa, and M. Okita Decreased food intake and body weight in pancreatic polypeptide overexpressing mice Gastroenterology 117 1999 1427 1432
46. A.M. Uhe, G.I. Szmukler, G.R. Collier, J. Hansky, K. O'Dea, and G.P. Young Potential regulators of feeding behavior in anorexia nervosa Am J Clin Nutr 55 1992 28 32
47. B. Vozarova de Courten, C. Weyer, N. Stefan, M. Horton, and A. DelParigi Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians Diabetes 53 2004 663 671
48. D.H. Weinberg, D.J. Sirinathsinghji, C.P. Tan, L.L. Shiao, N. Morin, and M.R. Rigby Cloning and expression of a novel neuropeptide Y receptor J Biol Chem 271 1996 16435 16438
49. C. Weyer, R.E. Pratley, S. Snitker, M. Spraul, E. Ravussin, and P.A. Tataranni Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure Hypertension 36 2000 531 537
50. C. Weyer, A.D. Salbe, R.S. Lindsay, R.E. Pratley, C. Bogardus, and P.A. Tataranni Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans? Metabolism 50 2001 223 230
51. D.C. Whitcomb, S.R. Taylor, and S.R. Vigna Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain Am J Physiol 259 1990 G687 G691